Tvardi Therapeutics, Inc. (TVRD)
4.28
+0.10
(+2.39%)
USD |
NASDAQ |
Dec 09, 16:00
4.28
0.00 (0.00%)
After-Hours: 16:06
Tvardi Therapeutics Shareholders Equity (Quarterly): 27.87M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Novavax, Inc. | -156.67M |
| Precigen, Inc. | 41.87M |
| Xencor, Inc. | 625.32M |
| Denali Therapeutics, Inc. | 926.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.02M |
| Total Liabilities (Quarterly) | 11.16M |
| Debt to Equity Ratio | 0.0082 |
| Current Ratio | 3.482 |
| Net Debt Paydown Yield | 2.57% |